health Life Biosciences Administers First Human Gene Therapy to Reverse Cellular Aging
Boston-based Life Biosciences has initiated the first human trial of ER-100, a gene therapy using OSK factors to rejuvenate cells and treat optic neuropathies like glaucoma.
